SETH SANDESH, CEO, reported a transaction classified as grant at Actinium Pharmaceuticals, Inc. involving 1027274.000000 shares for an estimated $0.00. Reported holdings after the transaction were 1965355.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
Stored Form 4 columns with their raw values
Badges describe filing facts only — not predictions.
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
Form 4 relationship flags and nearby filing context
Chief Executive Officer
Represents a grant of restricted stock units ("RSUs"). These RSUs vest as follows: 1/3 on the first anniversary of the date of grant, 1/3 on the second anniversary of the date of grant and 1/3 on the…
Represents a grant of RSUs. These RSUs vest fully on the third anniversary of the date of grant.
The stock options vest and become exercisable in fifty equal monthly tranches beginning on the date of grant.
0 other filings
0 recent txs